If hepatitis C therapy is so great, why isn't everyone doing it?

HCV therapy is highly effective but underutilized in the transplant setting, likely due to a combination of insurance barriers and lack of adherence to treatment guidelines by transplant professionals. See the article from Axelrod et al on page 2473.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of transplantation 2018-10, Vol.18 (10), p.2382-2383
1. Verfasser:	Brown, Robert S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents complication: infectious economics editorial/personal viewpoint health services and outcomes research Hepacivirus Hepatitis Hepatitis C Humans infection and infectious agents – viral: hepatitis C insurance Kidney Transplantation kidney transplantation/nephrology Kidney transplants liver transplantation/hepatology Liver transplants organ transplantation in general Quality of care quality of care/care delivery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	HCV therapy is highly effective but underutilized in the transplant setting, likely due to a combination of insurance barriers and lack of adherence to treatment guidelines by transplant professionals. See the article from Axelrod et al on page 2473.
ISSN:	1600-6135 1600-6143
DOI:	10.1111/ajt.14960